{
  "num_tested_probands": [
    3,
    0,
    0
  ],
  "num_positive_het_probands": [
    0,
    0,
    0
  ],
  "positive_phenotypes": [
    [
      "SS",
      "AS"
    ],
    []
  ],
  "num_compound_or_double_hets": [
    1,
    3,
    0
  ],
  "explanation": {
    "num_tested_probands": [
      "The probands of the three unrelated families were referred to DCRU because of prolonged duration of action of succinylcholine at a time, when it was not possible to perform genotyping.",
      "No probands were tested in these reports."
    ],
    "num_positive_het_probands": [
      "Only one relative of proband 2 was mentioned as being heterozygous for BCHE*FS126, but this individual is not a proband.",
      "No heterozygous carriers were reported in these studies."
    ],
    "positive_phenotypes": [
      "The biochemical tests indicated that two of the patients were homozygous for a silent variant and one was heterozygous for the atypical and a silent variant (AS).",
      "Phenotypic information was not provided in these reports."
    ],
    "num_compound_or_double_hets": [
      "Probands 3 was explicitly described as compound heterozygous for BCHE*328D and BCHE*142M.",
      "No compound or double heterozygotes were reported in these studies."
    ],
    "BCHE*115D*I3E4-14C": [
      "a known silent mutation"
    ],
    "BCHE*FS126": [
      "deletion of two nucleotides (376\u2013377) resulting in a shift in the translational reading frame and a truncated protein"
    ],
    "BCHE*328D": [
      "nucleotide substitution at position 983 leading to an amino acid substitution of alanine by aspartate"
    ]
  }
}